VC  Blackstone Life Sciences

https://www.blackstone.com/our-businesses/lif e-sciences





     Office Locations:

601 Gateway Boulevard, Suite 1270
South San Francisco, CA 94080
Phone: 650-238-5000
Fax: 650-238-5001

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Formerly Clarus Ventures, Blackstone Life Sciences (BXLS) works in partnership with the pharmaceutical, biotechnology and medical technology industries In 2018, Blackstone acquired Clarus, a leading global life sciences firm. Blackstone Life Sciences combines Clarus' scientific and clinical development expertise with Blackstone's knowledge and global network, access to capital, resources and infrastructure. The firm commits skill and scale to select, fund and advance what we believe to be the most promising life science products through hands-on involvement and directly applied expertise.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Dennis Henner Ph.D. Chief Scientific Advisor
    Emmett Cunningham MD, Ph.D., MPH Managing Director
    Jeffrey Leiden MD, Ph.D. Senior Advisor
    Kurt C. Wheeler Managing Director
    Michael Steinmetz Ph.D. Managing Director

     

    Portfolio companies include:

     

    Recent News: